Gary Gilkeson to Choroidal Neovascularization
This is a "connection" page, showing publications Gary Gilkeson has written about Choroidal Neovascularization.
Connection Strength
0.165
-
A targeted inhibitor of the complement alternative pathway reduces RPE injury and angiogenesis in models of age-related macular degeneration. Adv Exp Med Biol. 2010; 703:137-49.
Score: 0.085
-
A targeted inhibitor of the alternative complement pathway reduces angiogenesis in a mouse model of age-related macular degeneration. Invest Ophthalmol Vis Sci. 2009 Jul; 50(7):3056-64.
Score: 0.080